TrialPLoS medicine2014

Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.

RTS,S Clinical Trials PartnershipPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.